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ABSTRACT
Objective: The objective of the study was to evaluate the antidepressant activity of quercetin in monosodium glutamate (MSG) model of depressed 
male mice.
Methods: MSG was administered (500 mg/kg) to different groups of albino male mice daily for 21 days to induce depression. The interventions 
(Quercetin and imipramine) were started on day 9th and continued till 21st day. On 23rd day, mice are sacrificed, hippocampus and amygdala supernatant 
are subjected for analysis. p<0.05 was considered as statistically significant.
Results: There was a statistically significant reduction in interleukin (IL)-6 levels in animals treated with quercetin and imipramine compared to 
control group (p<0.001). There was also a statistically significant increase in brain-derived neurotrophic factor (BDNF) levels in quercetin with MSG 
groups (p<0.05) and imipramine with MSG groups (p<0.01). There was no statistically significant difference in IL-6 and BDNF levels between the 
groups of animals treated with quercetin (100 mg/kg) and imipramine (10 mg/kg) alone.
Conclusion: Quercetin appeared to have an antidepressant activity. More extensive research is required to substantiate and elucidate the role of 
quercetin in behavioral disorders such as depression.
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INTRODUCTION
Depression is a heterogenous mood disorder affecting person behavior, 
physical, and mental health. The prevalence of major depression is 
found to be 20–25% in women and 7–12% in men [1]. The presence 
of comorbid conditions such as myocardial infarction, cancer, and 
diabetes mellitus increases the risk of depression [2-4]. Early diagnosis 
and management of depression help in improving quality of life and 
preventing suicide; it has been found that suicide rates are 2 times more 
in depressed individuals than that in general population [5].
Monosodium glutamate (MSG) is commonly known as Aji-nomoto and it 
is widely used as food additive to enhance flavour and taste in processed 
foods. Despite its popular use, there are reports which indicate MSG 
is toxic to humans and laboratory animals at high doses [6]. MSG can 
overexcite neuronal cells to the point of damage or death, resulting in 
the release of inflammatory mediators, and increase in oxidative stress. 
In a study, it has been found that MSG at a dose of 500 mg/kg body 
weight intraperitoneally causes a depression such as effect and serves 
as experimental models to induce depression in mice [7].
Quercetin (3,3’,4’,5,7-pentahydroxyflavone) is a flavonoid found in fruits 
and vegetables such as apples, onions, and berries [8-9]. Quercetin 
is present as glycosides in foods and is deglycosylated to quercetin 
aglycone before passive absorption in the small intestine [10]. The half-
life of quercetin ranges between 11 and 28 h suggesting a correlation 
with plasma concentration on constant supplementation [11]. 
Quercetin is found to possess antioxidant, anticancer, neuroprotection, 
sirtuin gene modulating activity, and also as a phytoestrogen, mimicking 
natural estrogen hormone [12]. Hence, quercetin may work as a natural 
antidepressant; wherein current scenario lot of synthesized molecules 
are producing adverse effects.
In the current study, we evaluated antidepressant effects of quercetin 
on MSG-induced depression in male mice by estimating brain-derived 
neurotrophic factor (BDNF) and interleukin (IL)-6 levels in amygdala 
and hippocampus.
METHODS
MSG and quercetin were procured from Sisco Laboratories Pvt. Ltd., 
India. IL-6 and BDNF enzyme-linked immunosorbent assay (ELISA) 
kits were purchased from Sigma-Aldrich Pvt., Ltd., India. Standard 
imipramine tablets (Tofranil) from Novartis Laboratory Pvt., Ltd., India, 
all other materials were of analytical grade. Male mice of 3 months 
old (25–30 g) were used for study, after obtaining permission from 
Institutional Animal Ethics Committee (115/1999) K.S. Hegde Medical 
Academy. They were kept in a standard laboratory environment 
with laboratory food and water ad libitum. p<0.05 was considered as 
statistically significant.
The animals were grouped and administered drugs as follows 
(n=6 each).
Group 1 (Control): Normal saline (1 ml)
Group 2 (Positive control): MSG (500 mg/kg) orally for 21 days
Group 3  (Test drug): Quercetin (100 mg/kg) started on the 9th day and 
continued till 21st day
Group 4  (Standard): Imipramine (15 mg/kg) started on the 9th day and 
continued till 21st day
Group 5:  Positive control + Quercetin started on the 9th day and continued 
till 21st day
Group 6:  Positive control +Imipramine started on the 9th day and 
continued till 21st day
The test and standard drugs were administered orally after diluting 
in 1 ml of normal saline. The recommended dose of imipramine in a 
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human was used to calculate the dose for experimental animal [13]. The 
selection dose of quercetin used was based on a previous study [14].
IL-6 Estimation
For ELISA, the hippocampal tissue was homogenized in 1 ml buffer 
per 1 mg tissue wet weight. The standard manufacturer’s protocol was 
modified to optimize for the detection of cytokines in the brain tissue 
by the addition of fresh protease inhibitors to thawing homogenates 
and increasing the sample aliquot to 50 ml (in duplicate) as well as 
extending the sample incubation time from 2 h to 4 h. All samples were 
normalized for total protein. A standard curve was generated for IL-6 
based on the  standards provided [15].
BDNF estimation
BDNF levels in the amygdala were determined by sandwich-ELISA using 
monoclonal antibodies specific for BDNF. Total protein was measured 
by Bradford’s method using bovine serum albumin as standard [16].
Statistical analysis
Statistical analysis was performed using GraphPad prism version 5.0. 
One-way Analysis of variance was performed followed by Tukey’s test 
as post hoc. p<0.05 was considered as statistically significant.
RESULTS
Amygdala BDNF levels
The amygdala BDNF levels were significantly reduced in positive control 
(MSG) group when compared to control (Fig. 1). The intervention 
groups treated with MSG, both standard and test drug showed a 
significant increase in BDNF levels and there are no significant changes 
in imipramine and quercetin alone treated groups.
Hippocampal IL-6 levels
The hippocampal IL-6 levels were significantly increased in the positive 
control group (MSG) indicating neuroinflammation (Fig. 2). The 
intervention groups treated with MSG, both standard and test drug 
showed a significant decrease in IL-6 levels and there are no significant 
changes in imipramine and quercetin alone treated groups.
DISCUSSION
Depression is widely associated with other disorders such as obesity, 
hypothyroidism, diabetes mellitus, and also cancer. Depressed people 
are twice likely prone to committing suicide compared to the normal 
population [17]; hence, management of depression without adverse 
effects is essential to prevent morbidity and mortality associated with it.
In the present study, antidepressant effects of quercetin on MSG-induced 
depression were evaluated using the estimation of IL-6 and BDNF levels 
by ELISA in hippocampus and amygdala of male mice brain. Since majority 
antidepressants alter BDNF levels and also changes in BDNF levels takes 
place exactly after 1 week of antidepressant therapy which helps in 
understanding the therapeutic potential of antidepressants which takes 
weeks together to observe clinical benefits, thus BDNF estimation helps 
in understanding antidepressant actions of the test drug [18].
Recent evidence indicates the role of IL-6 as an inflammatory marker 
in depression; therefore, drugs which decreases IL-6 levels helps in the 
management of depression [19].
In study quercetin antagonized cognitive impairment induced by feeding 
mice with high-fat diet [20]. Quercetin activates the Nrf2-ARE pathway 
which provides neuroprotection against oxidative damage and cell death. 
More recent evidence suggests that the Nrf2-ARE pathway may modulate 
the formation and degradation of misfolded protein aggregates which are 
present in various neurodegenerative diseases (Parkinson’s, Alzheimer’s, 
and Huntington’s diseases) and amyotrophic lateral sclerosis [21].
In addition, quercetin also inhibits cytokine production by astrocytes. 
The cellular/molecular mechanisms for the anti-inflammatory effects 
of quercetin are not known, but a possible pathway may be related 
to the induction of PON2 [22] which has anti-inflammatory activity 
in addition to its antioxidant activity which may explain its role in 
decreasing inflammatory mediators involved in depression and 
exhibiting possible antidepressant effects.
At present, quercetin is considered to be a nutritional supplement 
and further research to improve its bioavailability and distribution 
in cerebrospinal fluid and its role in the treatment of neurological 
disorders has to be established.
CONCLUSION
Flavonoid quercetin has shown a significant increase in BDNF and 
decreases in IL-6 levels as compared to the standard antidepressant 
drug imipramine. However, further studies including the evaluation 
of its effect on the biochemical, molecular, and cellular pathway are 
required to establish its role as an antidepressant drug.
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Fig. 1: Effect of various treatments on amygdala brain-derived 
neurotrophic factor levels (*p<0.05 compared to control; 
**p<0.001 compared to positive control); n=6 in each group; data 
are represented as mean±S.D
Fig. 2: Effect of various treatments on hippocampus IL-6 levels 
(***p<0.0001 compared to control; **p<0.05 compared to positive 
control); n=6 in each group; data are represented as mean±S.D
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